Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group
| Autor: | Aapro, M.S, van Wijk, F.H, van der Burg, M.E.L, ten Bokkel Huinink, W, Vergote, I, Guastalla, J.P, Rosso, R, Kobierska, A, Beex, L.V.A, Namer, M, Splinter, T.E.W, Vermorken, J.B |
|---|---|
| Zdroj: | In European Journal of Cancer May 2003 39(8):1141-1143 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect